
Eric Newman MD (He/Him)
Hospital/Neurohospitalist, Neuroimmunology/Multiple Sclerosis
Autoimmune Neurology Fellow
Join to View Full Profile
4500 San Pablo Rd SJacksonville, FL 32224
Phone+1 904-953-2000
Dr. Newman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Eric Newman, MD, is a Neurologist based in Jacksonville, FL, with subspecialties in Hospital/Neurohospitalist and Neuroimmunology/Multiple Sclerosis. He received his BS in Neuroscience from Muhlenberg College, graduated from The University of Queensland Medical School, and completed his Neurology Residency at the University of Vermont Medical Center, followed by a Fellowship at the Mayo Clinic. Since 2023, he has been employed as a Neurohospitalist at St Luke's University Health Network. He has also contributed to scholarly research, his paper on the use of Eculizumab in Myasthenia Gravis treatment was published in the Therapeutics and Clinical Risk Management journal.
Education & Training
- Mayo ClinicFellowship, 2024 - 2025
- University of Vermont Medical CenterResidency, Neurology, 2019 - 2023
- The University of Queensland Medical SchoolClass of 2018
- Muhlenberg CollegeBS, Neuroscience, 2010 - 2014
Certifications & Licensure
- FL State Medical License 2024 - 2026
- PA State Medical License 2023 - 2026
- NJ State Medical License 2023 - 2025
- VT State Medical License 2019 - 2023
Publications & Presentations
PubMed
- Ventral Subpial and Central Cord Enhancement in Spinal Neurosarcoidosis: The Reverse Trident Sign.Amir M Jaafari, Eric Newman, Eoin P Flanagan, Sebastian A Lopez-Chiriboga, Sarosh R Irani
Neurology. 2025-04-22 - 2 citationsPractical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review.Waqar Waheed, Eric Newman, Marwa Aboukhatwa, Maryam Moin, Rup Tandan
Therapeutics and Clinical Risk Management. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: